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Biochemical changes and their relationship
with morphological and functional findings 
in pig heart subjected to lasting volume 
overload: a possible role of acylphosphatase 
in the regulation of sarcoplasmic reticulum 
calcium pump
 Abstract We evaluated the changes in sarcoplasmic reticulum (SR) func-
tion and the parallel hemodynamic and morphological modifications in a
heart subjected to volume overload. We also determined the levels of
acylphosphatase, a cytosolic enzyme, that could play a regulatory effect on SR
Ca2+ pump by hydrolyzing the phosphorylated intermediate of this transport
system. For this, swine hearts were subjected to volume overload by aorta-
cava shunt for 1, 2, or 3 months. Changes in heart contractility reflected mod-
ifications of SR function, whose reduction after 1 month of overload was fol-
lowed by a gradual recovery. A decrease in SERCA2a protein and mRNA con-
tent was shown from 1 month and remained for the following 2 months.
Phospholamban content and its phosphorylation status were not modified.
Acylphosphatase was unchanged at 1 month, but at 2 months this enzyme
exhibited an increased activity, protein and mRNA expression. Morphologi-
cal alterations consisting of the cytoskeletal architectures, intermyofibrillar
oedema, swollen mithochondria and abnormality of the membrane system
(T-tubule and SR cisternae) were particularly evident after 1 month but
almost disappeared after 3 months. These results suggest that our overloaded
hearts underwent a substantial recovery of their structural and biochemical
properties at 3 months after surgery. A possible involvement of acylphos-
phatase in the modification of SR function is discussed.
 Key words Cardiac volume-overload – sarcoplasmic reticulum Ca2+-
ATPase (SERCA2a) – acylphosphatase – phospholamban – ultrastructure
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Introduction
As an adaptive response to biomechanical stress myocar-
dial cells develop a compensatory hypertrophy through
the activation of several parallel and/or converging sig-
nalling pathways (9). Subsequently, there can be a tran-
sition to cardiac chamber dilatation that is associated
with a loss of viable myocytes, a decrease in contractile
elements, myofilament disarray and interstitial fibrosis.
In addition to these modifications, other signalling path-
ways can induce an impairment of cardiac excitation-
contraction coupling and severe defects in cardiac con-
tractile performance that are the clinical hallmarks of the
progression of heart failure (12, 22). Our understanding
of the biochemical mechanisms leading to heart failure is
still largely incomplete, but it is generally accepted that
altered intracellular calcium handling can play an impor-
tant role in the development of the systolic and diastolic
dysfunction which characterizes this disease (14). In this
regard, the sarcoplasmic reticulum (SR) function is cru-
cial for the movements of cytosolic Ca2+ during each
cycle of cardiac contraction and relaxation. It is well
known, that Ca2+ is released from SR to activate the con-
traction of heart muscle, while the subsequent re-accu-
mulation achieves relaxation. Cardiac SR Ca2+ ATPase
(SERCA2a) is a calcium pump whose activity is the rate-
determining factor of Ca2+ uptake into SR and, indirectly,
also of its release, which depends on the amount of cal-
cium stored in this structure: in this way SERCA2a can
regulate both cardiac relaxation and contractility. In the
action mechanism of SERCA2a Ca2+ uptake is tightly
coupled with ATP hydrolysis through a series of elemen-
tary steps involving the formation and the decomposi-
tion of an acylphosphorylated phosphoenzyme (EP)
intermediate (33). SERCA2a activity is itself regulated by
phospholamban (PLB), a membrane protein whose
phosphorylation leads to an enhancement of active Ca2+
transport (30). An additional regulatory effect on the SR
calcium pump might be exerted by acylphosphatase
(ACPase, EC 3.6.1.7), a cytosolic enzyme, well repre-
sented in cardiac muscle, that catalyzes the hydrolysis of
acylphosphates (6, 26, 28). In previous studies we have
shown, in fact, that acylphosphatase can interact with
SERCA2a and actively hydrolyze the EP intermediate of
this active transport system, an effect that results in
enhanced activity of the SR Ca2+ pump (23, 24).
Given this background, the goal of the present study
was to explore the changes in heart SR function and the
role of acylphosphatase related to the parallel hemody-
namic and morphological modifications arising in the
course of volume overload, a condition that can trigger
the above mentioned alterations and lead, ultimately, to
heart failure (21, 25). To this aim volume overload was
induced by an aorta-inferior cava shunt (31) for 1, 2 and
3 months in swine heart, chosen as a model for our stud-
ies since its structural and functional characteristics are
similar to those of the human heart. 
Methods
 Experimental model
The experimental protocol described in the study fol-
lowed the recommendations of the National Research
Council’ s Guide for the Care and Use of Laboratory Ani-
mals. Farm pigs (n = 16; four for each group), fasted
overnight, weighing 30 – 45 kg, were used. Animals were
premedicated with intramuscular azaperone (1 mg/kg),
ketamine (15 mg/kg) and diazepam (1 mg/kg). Anesthe-
sia was induced with ketamine (0.5 mg/kg) and atropine
(0.5 mg/kg) and the pigs were subsequently intubated
and ventilated with oxygen supplemented by with 50%
N2O and fluothane at 1 – 1.5% Pancuronium bromure
(0.1 mg/kg) was given to achieve muscle relaxation at the
beginning of the surgical procedure. The abdomen was
opened via a midline incision, and the inferior part of the
vena cava and abdominal aorta distal to the renal arter-
ies were cleaned of fat and adventitia. The shunt was per-
formed using a Dacron prosthesis (8-mm diameter)
which was sutured latero-laterally to the abdominal aorta
and to the inferior vena cava using partial occluding
clamps. When the anastomosis was performed, the
clamps were released, hemostasis was obtained and the
abdomen was closed. The animals were kept on antibi-
otic therapy for the first 5 days. At the time of sacrifice,
which was at 1, 2, or 3 months after surgery, the animals
were again anesthetized, subjected to hemodynamic and
echocardiographic measurements and then killed using
humanitarian methods. After sacrifice specimens of
myocardial tissue of left ventricle (LV) were taken for
biochemical and histological evaluation. Control animals
were simply anesthetized for hemodynamic and echocar-
diographic measurements and immediately sacrificed.
 Hemodynamic and echocardiographic measurements
Two 6F pigtail catheters were introduced into the left
femoral artery and advanced to monitor left ventricular
and descending aortic pressure. A Swan-Ganz catheter
was advanced from an external jugular vein to the pul-
monary artery to measure pulmonary capillary wedge
pressure and cardiac output (thermodilution). Two-
dimensional and M-mode echocardiographic studies
(2.25/3.5-Mhz transducer, SIM 5000) and relative meas-
urements were performed from the right parasternal area
and recorded on videotape (20); wall thickness and left
ventricular internal dimensions were measured accord-
ing to the recommendations of the American Society for
Echocardiography (29). Left ventricular mass (LVM) and
left ventricular volumes were calculated using validated
formulas (11, 34). End-systolic stress (ESS) was calcu-
lated from echocardiographic recordings in combination
with invasive left ventricular pressure (13). The contrac-
tile state was evaluated by measuring the ESS/end-sys-
tolic volume (ESV) ratio, which has proved useful in pre-
vious studies (8). Measurements were analyzed inde-
pendently by two experienced echocardiographers.
Inter-observer and intra-observer variabilities were 4.1 ±
0.5% and 2.5 ± 0.3% for cavity size and 3.7 ± 0.4% and
2.1 ± 0.3% for wall thickness, respectively.
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 Ca2+-ATPase Activity activity and Ca2+ uptake
measurements
Sarcoplasmic reticulum vesicles (SRVs), purified from
cardiac LV specimens according to Nediani et al. (25),
were measured for protein (4) and used to assay Ca2+-
ATPase activity and Ca2+ uptake.
Ca2+-ATPase total activity was assayed in a standard
reaction mixture containing 50 mmol/l Tris-HCl, pH 7.4,
3 mmol/l MgCl2, 100 mmol/l KCl, 5 mmol/l NaN3, 
50 µmol/l CaCl2, 3 mmol/l ATP, 1 mmol/l ouabain and 
50 µg/ml vesicle protein. Ouabain and sodium azide were
added to inhibit respectively sarcolemmal Na+,K+-
ATPase and mithochondrial ATPase, possibly present as
contaminants in SRV preparations. In these conditions a
free Ca2+ concentration of approximately 10 µmol/l was
calculated using the equations of Katz et al. (16). To
determine basal ATPase activity, the assays were carried
out in the presence of 1 mmol/l Tris-EGTA instead of
CaCl2. Reactions were started by the addition of ATP and
stopped after 10 min with 1 volume of ice-cold 20 %
trichloroacetic acid. After centrifugation (12,000xg for 
5 min), the amount of Pi released was measured by mala-
chite green procedure (3). Ca2+-dependent ATPase activ-
ity was calculated by subtracting the basal ATPase activ-
ity from the total Ca2+ATPase.
For Ca2+ uptake, the reaction mixture was the same as
for ATPase assays except that it included 45CaCl2 and
5mmol/l oxalate. After 30 s of incubation at 37°C, the
vesicles were separated from the medium by filtration
through a Millipore filter (0.45-µm pore size), and then
the filter was immediately washed twice with 4 ml of ice-
cold 20 mmol/l Tris-HCl, pH 7.4, 1 mmol/l EGTA, and
100 mmol/l KCl. Oxalate-facilitated 45Ca uptake was
measured as the difference between 45Ca influx into vesi-
cle at 0 time and at the end of incubation. Radioactivity
trapped on the filter was determined by liquid scintilla-
tion spectroscopy.
 ACPase activity measurement
Cardiac LVs specimens were homogenized with 4 vol-
umes of 0.1 mol/l HCl and centrifuged at 15000xg for 20
min. The supernatants were collected, adjusted to pH 7
and centrifuged at 15000xg for 20 min. The supernatants
of this centrifugation were assayed for protein and for
activity. ACPase activity was measured by a continuous
optical test at 283 nm, using benzoyl phosphate as
substrate (27). Benzoyl phosphate was synthesized
according to Camici et al. (7).
 RNA purification, reverse transcriptase (RT)-PCR and
quantitative analysis
For RT-PCR studies, total RNA was extracted from tis-
sues using TRIreagent (Sigma-Aldrich, Milan, Italy) and
purified according to the manufacturer's instructions.
Primers were designed using the published sequence
information from GenBank and corresponding to the
coding regions of the genes; the sequences of primers and
the cDNA sizes (bp) are summarized in Table 1. Reverse
transcriptase and PCR reactions were performed with a
commercial RT-PCR system (SuperScript One Step, BRL-
Life Technologies) on a Hybaid Thermocycler (Tedding-
ton, Middlesex, UK) using 125 ng of total RNA. To ensure
that an equivalent cDNA template was used in each reac-
tion, amplification of glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) was used as a control. The number
of cycles was optimized for each message to ensure lin-
earity between PCR amplified product and message and
were 30 cycles for ACPase, SERCA2a and PLB and 25 for
GAPDH, respectively.
RT-PCR products were resolved on 1.8% agarose gel
and digital images were captured from the stained gel
with a videocamera. Quantitative analyses were per-
formed via a Scion Image-Capture 2 board software and
density of PCR products at different time points were was
normalized over GAPDH expression.
 Western blot analysis of SERCA 2a, PLB and ACPase
Ten microgram of SRV protein mixtures, boiled for
SERCA2a and not boiled for PLB, were separated respec-
tively on 12% and 15% SDS-PAGE gels. ACPase separa-
tion was performed on the same 15% gel using 50 µg of
boiled supernatant protein mixtures. Then the gels were
electroblotted to nitrocellulose membranes and nonspe-
cific binding sites were blocked for 2 h in 5% BSA T-TBS
solution (50 mmol/l Tris-HCl, pH 7.4, 150 mmol/l NaCl,
0.1% Tween 20) with agitation. For immunoreaction a
monoclonal (mouse) anti-SERCA 2a ATPase antibody
(Affinity Bioreagents, Inc., Golden, CO), a polyclonal
(rabbit) anti-ACPase antibody, purified as previously
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Table 1 Acylphosphatase, SERCA 2a, phospholamban and GAPDH primers for 
RT-PCR
Primers Sequences 5’-3’ cDNA Sizes
bp  
Acylphosphatase 5’  ATGTATACAGAAGATGAAGC 113  
3’  ATGGTTTTTTCATTAGAAAAGTT
SERCA2a 5’  ACAATGGCGCTGTCTGTTCTA 311
3’  AAGCGGTTACTCCAGTATTGC
Phospholamban 5’  CCAGCTAAACACCGA 302
3’  TATTGGACTTTATCCATG
GAPDH 5’ ATGGTTTACATGTTCCAATATGAT 311
3’ GTTGTCATACTTCTCATGGTT 
SERCA2a sarcoplasmic reticulum calcium ATPase class 2a; GAPDH gliceraldehyde-
3-phosphate dehydrogenase
described (5, 19) and a monoclonal (mouse) anti-PLB
antibody (Upstate biotechnology, Lake Placid, NY) were
used. For detection, a second antibody, a peroxidase-
coniugated antirabbit IgG or antimouse IgG (Amersham
Pharmacia Biotech, Italy) and enchanced chemilumines-
cence assay (Amersham Pharmacia Biotech, Milan, Italy)
were used. After exposure to BIOMAX Light-1 film (East-
man Kodak Company, Rochester, NY), signals were
quantified using the program for image analysis and den-
sitometry Quantiscan (Biosoft, Cambridge, UK). The
same nitrocellulose used to reveal PLB protein expres-
sion was stripped and reprobed with 10 µg/ml mono-
clonal (mouse)anti-P-serine-16 antibody (Sigma-Aldrich,
Milan, Italy) to detect PLB-phosphorylation status.
Before quantification of immunoreactive bands of
SERCA2a, PLB and ACPase immunodetection of the sep-
arated proteins on western blots was ensured to be in the
linear range and electrophoretic transfer was complete in
the relevant molecular weight range. The data from den-
sitometric analysis were related to the amount of protein
used on the PAGE and were not significantly altered
when these values were related to -MHC proteins levels.
Quantitative data are expressed as percentage of control
value.
 Morphological analysis
Myocardial biopsies were taken from the left ventricle
wall of each animal, immediately fixed by immersion in
cold 2.5% glutaraldehyde in 0.1 mol/l cacodylate buffer,
pH 7.4 at room temperature and postfixed in 1% osmium
tetroxide in 0.1 mol/l phosphate buffer, pH 7.4 at room
temperature for ultrastructural analysis. The specimens
were then dehydrated in a graded acetone series, passed
through propylene oxide and embedded in Epon 812.
For each specimens two sets of semithin sections (2 µm
thick) were cut at different levels, stained with toluidine
blue sodium tetraborate and observed under light micro-
scope. Ultrathin sections obtained from the same speci-
mens were placed on 200 mesh copper grids and stained
with uranyl acetate and alkaline bismuth subnitrate.
Approximately a number of 200 tissue sections from con-
trol and volume overloaded myocardium were examined
under a transmission electron microscope (T.E.M) (JEOL
1010). In particular three independent ultrathin sets
(grids) were observed for each biopsies.
 Statistics
All data are presented as mean ± standard deviation
(S.D.). Comparisions between the different groups were
performed by ANOVA followed by the Bonferroni t-test.
A value of p < 0.05 was accepted as statistically signifi-
cant.
Results
 Echocardiographic and hemodynamic data
During the whole study period the aorta-cava fistula
remained pervious in all the operated pigs and no animal
showed signs of heart failure. The data in Table 2 reveal
a significant hypertrophy in the overloaded hearts since
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Table 2 Hemodynamic and echocardiographic changes after aorta-cava shunta,c
Months 0 1 2 3  
Heart rate (beats/min) 90  5 105  3*  98  8 95  3
Cardiac index (mL/kg min) 78   20 143  27* 152  42* 196  10*  
Systolic pressure (mmHg) 107  4 108  3 107  2 109  3
LVMi (g/kg) 2.69  0.54  4.54  0.59* 4.97  0.46*   6.08  0.18*o†
ESS/ESVi (kdyne/cm2) (mL/kg) 124  22 87  14* 103  14 106  9 
PWP (mmHg) 12  1 20  3* 14  2† 13  1†
RWT 0.42  0.02  0.41  0.03 0.39  0.03   0.36  0.02
Body weight (kg) 35  5 38  4 40  3 43  4
a Values are means  S.D.
b *p < 0.05 vs 0 (control); † p < 0.05 vs 1 months; o p < 0.05 vs 2 months.
c LVMi left ventricular mass, normalized for body weight; ESS/ESVi end-systolic stress/end-systolic volume normalized for body weight; PWP pulmonary wedge pressure;
RWT relative wall thickness
1 month after surgery; at 3 months of overload the mean
left ventricular mass, normalized for body weight
(LVMi), taken as an index of hypertrophy, was about
doubled with respect to the control value. A similar effect
was observed for the cardiac index. The values calculated
for the ratio end-systolic stress/end-systolic volume (8)
normalized for body weight (ESS/ESVi) indicate a loss of
contractility at 1 month after surgery and a subsequent
recovery of this property. These modifications of left ven-
tricle contractility corresponded to changes of opposite
sign observed for pulmonary wedge pressure.
 Biochemical data
To investigate the changes induced by our volume-over-
load conditions in SR Ca2+ pump function we measured
the rates of Ca2+-dependent ATP hydrolysis and of active
Ca2+ uptake in cardiac SRVs isolated from LV at 1, 2 and
3 months from surgery. As shown in Fig. 1A and 1B, 
1 month after the establishment of the arterial-venous
shunt the overloaded hearts exhibited a significant
decrease in both these activities whose mean levels were
about 45% lower those observed in the hearts of control
animals. Subsequent measurements showed a progres-
sive recovery of SR Ca2+ ATPase activity and Ca2+ uptake
in the overloaded hearts since the mean differences from
the control values were reduced at by about 25% after 2
months and became statistically not significant 3 months
after surgery. The time courses of Ca2+-ATPase activity
and Ca2+ uptake were very similar, so that the Ca2+/ATP
ratio appeared to be substantially unchanged at all the
considered times (data not shown). ACPase activity did
not show significant changes after 1 month of overload
but 2 months it was significantly increased reaching at 
3 months a mean level that was about 30% higher than
the control value (Fig. 1C). 
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Fig. 1 Time-course of SR Ca2+-ATPase activity (A), Ca2+ uptake (B), and ACPase
activity (C) in control heart (0) and in hearts subjected to 1, 2, 3 months of volume
overload. All the activities are expressed as mol/min/mg SR vesicle protein. Each
value represents the mean value of four experiments  S.D. * p < 0.05 vs control;
 p < 0.05 vs 1 month;  p< 0.05 vs 2 months.
Fig. 2 Top: Representative Western blotting of SERCA2a (A), and ACPase (B) from
control heart (0) and hearts subjected to 1, 2, 3 months of volume overload. Bottom:
Quantitative data. Each bar represents the mean value  S.D. of four different blots.
Signals were quantified by densitometric analysis and are expressed as percentage
of control value. * p < 0.05 vs control;  p < 0.05 vs 1 month;  p < 0.05 vs 2 months.
A
A
B
C
B
To assess whether the observed alterations of active
Ca2+ transport in SR were due to changes in the expres-
sions of the proteins involved in this process, we meas-
ured the mass concentrations and the mRNA levels of the
SERCA2a, PLB and ACPase. Immunochemical detection
of SERCA2a (Fig. 2A), obtained with highly specific
monoclonal antibody, revealed a single band at the
expected position of 110 kDa. Densitometric analysis
indicated that the concentration of this protein was sig-
nificantly decreased in the overloaded hearts compared
to the control 1 month after surgery and no further
changes were evident at the following times. Immuno-
chemical detection of PLB in unboiled protein samples
using monoclonal antibody revealed a single band at the
expected position of 27 – 29 kDa (Fig. 3A), corresponding
to the pentameric form of this protein, and no significant
difference was detected in PLB protein levels between
control and volume-overloaded hearts, at all the consid-
ered times. Equally, PLB-phosphorylation status was not
modified, as judged from the immunodetectable signals
revealed using a specific antibody that exclusively detects
PLB at its serine-16 phosphorylated site (Fig. 3B) (10).
Western blot analysis of ACPase, using specific poly-
clonal antibodies obtained as previously described (5,
19) revealed a well separated band at 11 kDa (Fig. 2B)
whose quantification indicated that the mass concentra-
tion of this enzyme significantly increased in comparison
with the control value as from at 2 months of volume
overload. 
As shown in Fig. 4A and 4C, the myocardial levels of
both SERCA2a- and ACPase-mRNAs, normalized to
GAPDH, showed modifications that paralleled the above
reported changes in the expression of the corresponding
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Fig. 3  Top: Representative Western blotting of PLB (A), and of PLB phosphoryla-
tion at Ser16 residue (B) from control heart (0) and hearts subjected to 1, 2, 3
months of volume overload. Bottom: quantitative data. Each  bar represents the
mean value  S.D. of four different blots. Signals were quantified by densitometric
analysis and are expressed as percentage of control value. No significant changes
were observed for PLB protein expression and for its Ser16 phosphorylation. 
Fig. 4 Top: RT-PCR analysis for SERCA2a (A), PLB (B), ACPase (C) and GAPDH
mRNAs, from control heart (0) and hearts subjected to volume overload (1,2,3). Bot-
tom: Quantitative data. Each bar represent the mean  S.D. of 3-4 values of ampli-
fication products normalized to GAPDH. * p < 0.05 vs control;  p < 0.05 vs 1
month;  p < 0.05 vs 2 months.
A
B
C
A
B
proteins, while the PLB-mRNA remained unchanged as
well as its protein concentration (Fig. 4B).
 Morphological analysis
The morphological analyses of the volume overloaded
myocardium revealed marked disruptions in the
cytoskeletal architecture of cardiomyocytes subjected to
1 month of increased workload. These modifications, in
sharp contrast with the organized assembly of the con-
tractile apparatus in control hearts (Fig. 5A), consisted of
focal clumps of contracted myofibrils interspersed with
areas of overstretched myofilaments and/or of rarefac-
tion of sarcomeres (Figs. 5B, C, D). However, other
organelles in these fibers showed abnormalities. Indeed,
in association with pronounced intermyofibrillar edema,
mitochondria appeared swollen with loss of cristae and
the tubular system with the adjacent cisternae of sar-
coplasmic reticulum were often dilated (Fig. 5D). These
modifications could also be identified, although to a
lesser extent, in cardiomyocytes subjected to 2 months of
volume overload, and surprisingly they further attenu-
ated 3 months after surgery. At this time, in fact, the
cytoskeletal organization seemed almost completely
recovered in most of the cardiomyocytes (Figs. 6A-D)
except for the persistence of focal areas of sarcomere
hypercontractions, mainly located beneath the sar-
colemma (Fig. 6C). Moreover, the 3-month-overloaded
cardiomyocytes showed mitochondria with tightly
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Fig. 5 A Myocardium from control swine heart. Cardiomyocytes show a normal
myofibrillar structure. Semithin sections stained with Toluidine Blue. L.M. X750. (B-
D) Myocardium from pig hearts subjected to 1 month of volume overload. B Virtu-
ally all the fibers show grossly disorganized myofibrillar network (arrows). Semithin
sections stained with Toluidine blue L.M.X750. C Extensive hypercontractions
through cardiomyocytes. Clumps of dark myofibrillar materials (arrows) are associ-
ated with disrupted sarcomeres (arrowhead)(TEMX7,000) and D with overstretched
myofilaments. Intermyofibrillar edema, swollen mitochondria (arrows) with
separated and disrupted cristae and dilated elements of T tubules and sarcoplasmic
reticulum (arrowhead) are also evident. (TEMX13,000). Each figure is representative
at least 3 independent observations from randomly selected mesh areas.
Fig. 6 Myocardium from swine hearts subjected to 3 months of volume overload.
A Most of the fibers display a normal myofibrillar organization, apart from the per-
sistence of occasional focal areas of hypercontraction (arrows) (LMX750). B Several
cardiomyocytes in cross section show normal  mitochondria interspersed with reg-
ularly arranged myofilaments and absence of oedema (TEMX7,000). C Higher mag-
nification of B showing a dark area of myofilament hypercontraction. Mitochondria
contain regularly packed cristae and the cisternae of sarcoplasmic reticulum (arrow-
heads) display a quite normal appearance (TEMX30,000). D Longitudinal section
through a cardiomyocyte showing sarcomeres in register (TEMX10,000).
packed cristae, normal triads and no signs of intracellu-
lar edema (Figs. 6C, D). 
Discussion
The results of hemodynamic and echocardiographic
measurements indicate that our experimental conditions
induce a marked hypertrophy, as shown by the LVMi
data, that, owing to the RWT values, was eccentric. This,
however, did not result in left ventricle pump dysfunc-
tion, since the cardiac index progressively increased dur-
ing the study period. In our model, the ESS/ESVi ratio,
assumed as an index of contractility (8), showed a reduc-
tion after 1 month of overload, subsequently increased,
so that no significant differences from control values
were evident 3 months after surgery. These findings sug-
gest the development of adaptive process(es) and, in con-
nection with this, it is noteworthy that a similar time
course was observed for the changes in SR function,
notably for Ca2+ uptake and Ca2+–ATPase activity. 
In order to elucidate the mechanism(s) responsible
for the modifications of SR activity, we evaluated the
expression, as protein and as mRNA, of SERCA2a and of
its best-known modulator phospholamban. Similar
measurements, besides the determination of catalytic
activity, were performed for acylphosphatase, which we
propose as a candidate for an additional regulatory role
in Ca2+ transport through SR membrane.
As stated in the Results, although Ca2+ pump activity
was significantly decreased at 1 month after surgery, it
was partially restored at 2 months and after 3 months of
overload it was not significantly different from the con-
trol value. These modifications, however, were not justi-
fied by the changes in SERCA2a protein expression
because this decreased at 1 month of volume overload,
reaching a level which was not modified both at 2 and or
3 months after surgery. The changes in SERCA2a protein
concentrations paralleled those in the content of the cor-
responding mRNA, in agreement with other reports (1,
18) showing that hemodynamic overload can trigger reg-
ulatory mechanisms acting at a transcriptional level on
the genes codifying for proteins involved in cardiac intra-
cellular calcium handling. Since these findings suggested
the involvement of mechanisms acting on the functional
properties rather than on the mass concentration of
SERCA2a, we examined the behavior of phospholamban,
the best-known modulator of the SR Ca2+ pump. In this
connection it is accepted that an enhanced Ca2+ pump
activity may result either from a decrease in the relative
PLB/SERCA ratio or from an increase in PLB phospho-
rylation status (17). Our measurements, however, indi-
cated that phospholamban, both at the early and the late
phase of overload, does not undergo significant changes
in its expression (as protein and  as mRNA) nor in its
phosphorylation status at the serine-16 residue, which is
the main target in physiological myocardial regulation
and the prerequisite for other residue phosphorylations
(15). These results allow us to exclude an involvement of
PLB in the changes of SR function observed in our over-
loaded hearts, notably in the modifications of Ca2+ pump
activity at different times following surgery. In our opin-
ion this is not surprising since, despite its importance to
normal cardiac function, the role of PLB in heart patho-
physiology remains largely unknown and the reports on
this subject are often controversial (30). Conversely,
acylphosphatase levels were unchanged with respect to
control values at 1 month of overload: at 2 months, how-
ever, this enzyme exhibited a significant increase not
only in its activity but also in its protein and mRNA
expression. As mentioned in the Introduction, we
showed that acylphosphatase can affect the functional
properties of SERCA2a stimulating Ca2+ pump activity.
Our studies (23, 24) also suggest that the acylphosphatase
effect was mainly due to its hydrolytic activity on the
phosphoenzyme intermediate of SR Ca2+ pump; how-
ever, because of a structural analogy with phospholam-
ban, acylphosphatase may also interact with SERCA2a,
taking the place of unphosphorylated phospholamban
and removing the inhibitory effect of this regulatory
protein. In any case, given this stimulatory effect – in
whichever manner it is exerted – and the time course of
acylphosphatase levels during the study period, it seems
reasonable to propose that our enzyme may be responsi-
ble, at least in part, for the recovery of Ca2+ pump activ-
ity observed after the first month of overload and result-
ing in the restoration of control levels at 3 months. Also
the morphological findings were consistent with the acti-
vation of cellular adaptive processes in cardiomyocytes
subjected to a prolonged period of volume overload. The
marked alterations observed after 1  month of volume
overload, cytoskeletal changes and abnormalities of the
membrane system (T tubule system and SR cisternae),
are probably a consequence of the abnormal mechanical
forces acting on cardiomyocytes because of the new
hemodynamic condition. Another factor contributing to
cytoskeletal disorganization may be a limited proteolysis
caused by calcium activated proteases (2, 32). Indeed the
reduced activity of the SR Ca2+ pump that we found, espe-
cially after 1 month of overload, may result in an upreg-
ulation of sarcoplasmic Ca2+ levels and in the consequent
activation of these enzymes. In any case, the morpholog-
ical alterations, as well as the biochemical changes, were
markedly attenuated at 2 months and almost disap-
peared at 3 months from after surgery, thus, suggesting
a a marked morphofunctional recovery of our over-
loaded hearts.
In conclusion, the present study provides some orig-
inal findings about the hemodynamic, biochemical and
morphological changes occurring in swine heart subject
to a lasting volume overload. In particular, our results
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suggest a novel mechanism, based on acylphosphatase,
that could play a role in the modifications of cardiac SR
function associated with an increased working. In our
opinion, further studies focusing on the relevance of this
mechanism in other experimental conditions of cardiac
overload and in spontaneous cardiomyopathies would
be of interest.
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